CompletedNot applicableNCT01554384

Trial of Point-of-treatment Xpert MTB/RIF Assay

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Cape Town
Principal Investigator
Keertan Dheda, MD PhD
University of Cape Town
Intervention
Xpert MTB/RIF assay(procedure)
Enrollment
1472 enrolled
Eligibility
18 years · All sexes
Timeline
2010 – 2012

Study locations (4)

Collaborators

Biomedical Research and Training Institute · University of Zimbabwe · University of Zambia · Medical Research Council, South Africa · Mbeya medical research program · McGill University · Radboud University Medical Center · University of Cape Town Lung Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01554384 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials